Scotland eyes stenting to treat lower-limb PAD (peripheral arterial disease):
This article was originally published in Clinica
Executive Summary
Scotland has decided not to conduct a health technology assessment on the use of stents in the treatment of peripheral arterial disease (PAD) of the lower limbs, but calls for research to be conducted in this area. NHS Quality Improvement Scotland found that current evidence would add little or no value to the study Endovascular stents for intermittent claudication, published by the Cochrane Review in 2002. Scotland's HTA body believes that "high quality randomised controlled trials are imperative" to determine whether percutaneous transluminal angioplasty (PTA) combined with stenting is clinically and cost effective in the treatment of PAD. Lower-limb PAD affects some 3% of people aged under 60 years and 20% of under-75s. The main symptom of PAD is intermittent claudication, which includes activity-induced pain and weakness. Treatment options include bypass surgery, endarterectomy and PTA (with or without a stent).
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.